Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. BRIEF- Bayer says phase III trial of Sorafenib does not meet primary endpoint in patients with advanced breast cancer

    Headlines

    Fri, 25 Jul 2014

    July 25 (Reuters) - Bayer AG : * Says phase III trial of sorafenib with capecitabine does not meet primary

  2. BRIEF- Bayer says Eylea trial shows sustained improvement in vision

    Headlines

    Fri, 18 Jul 2014

    July 18 (Reuters) - Bayer AG : * Says two-year results from Phase III trial of Eylea eye drug show sustained improvement in vision for people with diabetic macular edema

  3. Compugen achieves first milestone in Bayer collaboration

    Headlines

    Mon, 7 Jul 2014

    basis for its collaboration with Bayer HealthCare ( OTCPK:BAYRY ) ( OTCPK:BAYZF ..... a $1.2M milestone payment from Bayer . The two firms formalized their ..... therapeutic antibodies developed by Bayer against the checkpoint proteins

  4. China approves Bayer deal to buy Dihon, other deals

    Headlines

    Fri, 4 Jul 2014

    SHANGHAI, July 4 (Reuters) - The Chinese Ministry of Commerce's anti-monopoly bureau has approved German drugmaker Bayer AG 's deal for traditional Chinese medicine (TCM) drugmaker Dihon Pharmaceutical Group Co, in a raft of deals approved on Friday.

  5. CHMP recommends label expansion for Eylea

    Headlines

    Fri, 27 Jun 2014

    Agency (EMA) approve Regeneron Pharmaceuticals ' ( REGN ) Eylea ( aflibercept ..... occlusion (CRVO). Regeneron and Bayer Healthcare ( OTCPK:BAYRY ) ( OTCPK ..... product in the U.S. while Bayer Healthcare has the license for exclusive

  6. BRIEF- Bayer says Eylea receives EU recommendation for diabetic macular edema

    Headlines

    Fri, 27 Jun 2014

    June 27 (Reuters) - Bayer AG : * Says aflibercept (Eylea) receives positive CHMP opinion for the treatment of visual impairment due to diabetic macular edema in EU

  7. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    Headlines

    Thu, 26 Jun 2014

    order to acquire Cadence Pharmaceuticals . While the deal gives ..... example, we only downgraded Bayer 's BAYRY "> BAYRY issuer ..... will significantly expand Bayer 's already well-positioned ..... material science toward Bayer 's health-care operations

  8. BRIEF- Bayer says Bayer Healthcare , Dimension Therapeutics to develop gene therapy for Hemophilia A

    Headlines

    Mon, 23 Jun 2014

    June 23 (Reuters) - Bayer AG : * Says Bayer healthcare and dimension therapeutics to develop novel gene

  9. BRIEF- Bayer receives approval for Nexavar in Japan for treatment of thyroid cancer

    Headlines

    Fri, 20 Jun 2014

    June 20 (Reuters) - Bayer AG : * Says receives approval for Nexavar (sorafenib) in Japan for treatment of

  10. BRIEF- Bayer's Xofigo attested to have considerable benefit by German reimbursement agency

    Headlines

    Thu, 19 Jun 2014

    June 19 (Reuters) - Bayer AG : * Says Xofigo drug attested to have considerable benefit in treating certain

« Prev12345Next »
Content Partners